🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy and safety of a fixed ...
Status
Completed
Location
Sites in USA
Start Date
2008-07
Trial ID
NCT00739596
Treatments Being Tested
The purpose of the study is to evaluate the blood pressure lowering effect ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2008-11
Trial ID
NCT00797316
Treatments Being Tested
This study is designed to compare the blood pressure lowering efficacy of a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT01922141
Treatments Being Tested
The goal of this project is to evaluate the chronic effect (8 weeks) of RAS...
Status
Completed
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2011-10
Trial ID
NCT01519635
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of initial ...
Status
Completed
Location
Sites in USA
Start Date
2008-09
Trial ID
NCT00760266
Treatments Being Tested
Study to Evaluate the Efficacy and Safety of Aliskiren Hydrochlorothiazide ...
Status
Completed
Location
Investigative Site
Start Date
2008-08
Trial ID
NCT00772577
Treatments Being Tested
The purpose of the study is to evaluate the blood pressure lowering effect ...
Status
Completed
Location
Sites in USA
Start Date
2008-11
Trial ID
NCT00787605
Treatments Being Tested
The purpose of the study is to compare the combination of aliskiren, amlodi...
Status
Completed
Location
K and S Research Services
Start Date
2009-06
Trial ID
NCT00942994
Treatments Being Tested
High blood pressure (hypertension) is an important cause of myocardial infa...
Status
Completed
Location
UMC Utrecht
Start Date
2010-08
Trial ID
NCT01138423
The purpose of this study is to assess efficacy of aliskiren for reducing c...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-06
Trial ID
NCT01176032
Treatments Being Tested